Real-time Estimate
Cboe Europe
06:56:49 2024-05-14 am EDT
|
5-day change
|
1st Jan Change
|
1,287
GBX
|
-1.00%
|
|
-1.39%
|
-16.17%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,862
|
1,583
|
2,068
|
1,451
|
1,221
|
1,130
|
-
|
-
|
Enterprise Value (EV)
1 |
1,789
|
1,510
|
1,999
|
1,415
|
1,228
|
1,093
|
1,078
|
1,065
|
P/E ratio
|
20.2
x
|
29.3
x
|
28.4
x
|
19.1
x
|
19.9
x
|
20.2
x
|
16.1
x
|
14.1
x
|
Yield
|
2.76%
|
2.52%
|
2.5%
|
3.57%
|
4.24%
|
4.6%
|
5.02%
|
5.27%
|
Capitalization / Revenue
|
6.33
x
|
5.95
x
|
6.75
x
|
4.26
x
|
3.98
x
|
3.71
x
|
3.44
x
|
3.21
x
|
EV / Revenue
|
6.09
x
|
5.68
x
|
6.53
x
|
4.15
x
|
4
x
|
3.59
x
|
3.28
x
|
3.02
x
|
EV / EBITDA
|
14.7
x
|
15.6
x
|
17.5
x
|
12
x
|
12
x
|
11.7
x
|
9.82
x
|
8.65
x
|
EV / FCF
|
31.2
x
|
33.9
x
|
23.5
x
|
41
x
|
384
x
|
13.9
x
|
12.6
x
|
12.3
x
|
FCF Yield
|
3.21%
|
2.95%
|
4.26%
|
2.44%
|
0.26%
|
7.18%
|
7.93%
|
8.15%
|
Price to Book
|
4.03
x
|
3.31
x
|
4.07
x
|
2.97
x
|
-
|
2.31
x
|
2.2
x
|
2.12
x
|
Nbr of stocks (in thousands)
|
86,283
|
86,463
|
86,838
|
86,886
|
86,930
|
86,959
|
-
|
-
|
Reference price
2 |
21.58
|
18.31
|
23.82
|
16.70
|
14.05
|
13.00
|
13.00
|
13.00
|
Announcement Date
|
12/5/19
|
12/9/20
|
12/6/21
|
12/6/22
|
12/5/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
294
|
266
|
306.3
|
341
|
307
|
300.3
|
328
|
351.6
|
EBITDA
1 |
122
|
96.7
|
114.5
|
118
|
102.2
|
93.83
|
109.9
|
124.2
|
EBIT
1 |
104.1
|
76
|
92.6
|
96.4
|
80.7
|
71.04
|
86
|
99.38
|
Operating Margin
|
35.41%
|
28.57%
|
30.23%
|
28.27%
|
26.29%
|
23.66%
|
26.22%
|
28.27%
|
Earnings before Tax (EBT)
1 |
104.7
|
63.5
|
92.5
|
87.7
|
72.5
|
68.15
|
85.02
|
101.2
|
Net income
1 |
92.4
|
54.2
|
73.2
|
76.2
|
61.7
|
56.17
|
71.47
|
83.25
|
Net margin
|
31.43%
|
20.38%
|
23.9%
|
22.35%
|
20.1%
|
18.7%
|
21.79%
|
23.68%
|
EPS
2 |
1.069
|
0.6250
|
0.8400
|
0.8730
|
0.7050
|
0.6437
|
0.8131
|
0.9390
|
Free Cash Flow
1 |
57.4
|
44.5
|
85.2
|
34.5
|
3.2
|
80.18
|
87.9
|
86.9
|
FCF margin
|
19.52%
|
16.73%
|
27.82%
|
10.12%
|
1.04%
|
26.7%
|
26.8%
|
24.72%
|
FCF Conversion (EBITDA)
|
47.05%
|
46.02%
|
74.41%
|
29.24%
|
3.13%
|
85.45%
|
79.98%
|
69.95%
|
FCF Conversion (Net income)
|
62.12%
|
82.1%
|
116.39%
|
45.28%
|
5.19%
|
142.75%
|
122.99%
|
104.38%
|
Dividend per Share
2 |
0.5956
|
0.4614
|
0.5956
|
0.5956
|
0.5956
|
0.5958
|
0.6529
|
0.6848
|
Announcement Date
|
12/5/19
|
12/9/20
|
12/6/21
|
12/6/22
|
12/5/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
-
|
151.5
|
114.5
|
150.9
|
155.4
|
160.1
|
180.9
|
162.2
|
144.8
|
139.3
|
EBITDA
|
-
|
-
|
-
|
57.5
|
-
|
-
|
-
|
53.1
|
-
|
-
|
EBIT
|
-
|
-
|
23.8
|
47
|
45.6
|
48.6
|
-
|
42.6
|
-
|
-
|
Operating Margin
|
-
|
-
|
20.79%
|
31.15%
|
29.34%
|
30.36%
|
-
|
26.26%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
13.6
|
46.6
|
-
|
-
|
-
|
39.1
|
-
|
-
|
Net income
|
-
|
-
|
-
|
40.7
|
-
|
-
|
-
|
33.7
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
26.97%
|
-
|
-
|
-
|
20.78%
|
-
|
-
|
EPS
|
-
|
0.4740
|
0.1510
|
0.4680
|
-
|
-
|
-
|
0.3880
|
-
|
-
|
Dividend per Share
|
0.4614
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1342
|
-
|
-
|
Announcement Date
|
12/5/19
|
5/11/20
|
12/9/20
|
5/10/21
|
12/6/21
|
5/9/22
|
12/6/22
|
5/9/23
|
12/5/23
|
5/13/24
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
6.3
|
-
|
-
|
-
|
Net Cash position
1 |
72.8
|
73.1
|
69
|
36.2
|
-
|
37.4
|
52.7
|
66
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.0616
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
57.4
|
44.5
|
85.2
|
34.5
|
3.2
|
78.5
|
85.5
|
86.7
|
ROE (net income / shareholders' equity)
|
19.4%
|
11.5%
|
14.8%
|
15.3%
|
12.5%
|
11.3%
|
13.9%
|
15.9%
|
ROA (Net income/ Total Assets)
|
16.8%
|
9.98%
|
12.6%
|
12.1%
|
9.73%
|
8.3%
|
11.1%
|
14.1%
|
Assets
1 |
550
|
542.9
|
582.4
|
628.4
|
634.1
|
657.6
|
642.5
|
581
|
Book Value Per Share
2 |
5.360
|
5.530
|
5.850
|
5.620
|
-
|
5.630
|
5.920
|
6.120
|
Cash Flow per Share
2 |
0.9300
|
0.8000
|
1.460
|
0.9200
|
0.4800
|
1.040
|
1.190
|
1.330
|
Capex
1 |
22.7
|
24.9
|
41.9
|
45.5
|
38.5
|
32.5
|
30
|
31.1
|
Capex / Sales
|
7.72%
|
9.36%
|
13.68%
|
13.34%
|
12.54%
|
10.67%
|
9.15%
|
8.83%
|
Announcement Date
|
12/5/19
|
12/9/20
|
12/6/21
|
12/6/22
|
12/5/23
|
-
|
-
|
-
|
Average target price
14.96
GBP Spread / Average Target +15.12% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.17% | 1.42B | | +16.84% | 66.18B | | +0.88% | 49.24B | | +16.50% | 41.72B | | +22.44% | 26.16B | | +11.75% | 19.75B | | +3.13% | 17.5B | | -23.12% | 15.63B | | +2.57% | 15.43B | | -8.98% | 15.46B |
Other Specialty Chemicals
|